Abiopharma

Clinical trial NCT06510205: enrollment: 5000 → 6111 participants.

Clinical trial NCT07597928 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-12 → 2026-05-13

Clinical trial NCT07013643 updates: 1. completion date: 2026-12-25 → 2027-07-09 2. primary completion date: 2026-12-25 → 2027-07-09

Clinical trial NCT06380179 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2026-03-02 3. primary completion date: 2025-12-01 → 2026-03-02 4. enrollment: 116 → 29 participants 5. enrollment type: ESTIMATED → ACTUAL 6. collaborators added: Uniformed Services University of the Health Sciences 7. collaborators removed: Uniformed Services University …

Deadline Approaching: Via Transportation, Inc. (VIA) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Dana Incorporated (NYSE: DAN)

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Roku, Inc. (NASDAQ: ROKU)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Payoneer Global Inc. (NASDAQ: PAYO)

Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Law Offices of Howard G. Smith Encourages BitGo Holdings, Inc. (BTGO) Shareholders To Inquire About Securities Fraud Class Action